NCI awards Carevive with the only Fast-Track Phase I/II contract supporting the development of an innovative symptom management and electronic patient-reported outcome solution.
A message from our CEO. At Carevive, we wholeheartedly support the need for change in this country. A change to achieve a society where equality, opportunities, and safety are rights that are undeniably provided to all.
Carevive OPT-IN® is a novel real-world Patient Experience database consisting of EHR-derived clinical data and longitudinal Patient-Reported Outcomes (PRO).
Carevive is aligned with and strongly supports CMS’ announcement of the OCF Model as this will benefit patients and improve care. We believe unequivocally this program provides an invaluable opportunity for U.S.-based cancer programs to transform their practice in delivering better quality, patient-centered, value-based care.
Authors: Ashley Leak Bryant PhD, RN1 ; Ya-Ning Chan RN, MSN1 ; Jaime Richardson RN, BSN1; Matthew Foster, MD1 ; Debra Wujcik, PhD, RN2 1 The University of North Carolina at Chapel Hill School of Nursing; 2 North Carolina Cancer Hospital, Lineberger Comprehensive Cancer Center, Division of Hematology and Oncology, The University of North Carolina at Chapel Hill 3 Carevive…
Authors: Debra Wujcik, PhD, RN1 ; Susie Owenby, RN1 ; Moh’d Khushman MD2 ; Daniel Cameron, MD2; Thomas Butler, MD2; Cathy Tinnea RN2, Austin Cadden MPH2, Jennifer Pierce, MD2, Sachin Gopalkrishna Pai, MD2 1 Carevive Systems, Inc, Miami, FL 2 University of South Alabama Mitchell Cancer Institute Background Treatment of lung cancer has seen a paradigm shift in recent years.…
We are delighted to announce that Carevive was selected to be a part of Silicon Valley Health Batch X Program at Plug and Play. The Plug and Play Health team evaluated over 900 startups across the globe, and approximately 30 companies were selected by their Corporate Partners to present at Plug and Play’s Selection Day on February 27, 2020, at…
Carevive Systems, a leading oncology-focused health technology company, announced today that it has received Series C funding from new investors Philips Health Technology Ventures and Debiopharm Innovation Fund.
Carevive's Debra Wujcik, PhD, RN, AOCN, FAAN along with Jeannine M. Brant, PhD, AOCN, FAAN from Billings Clinic presented a poster at the 2019 MASCC/ISOO Annual Meeting titled "Tablet-Based Expanded Pain Assessment Reveals Severe Flares and End of Dose Pain at Home". Background Cancer pain prevalence is high (52%-77%) and includes pain flares and end-of-dose failure. Poorly controlled pain contributes…